Stocks and Investing Stocks and Investing
Wed, May 18, 2022
Tue, May 17, 2022

Joanne Wuensch Maintained (TNDM) at Strong Buy with Decreased Target to $130 on, May 17th, 2022


Published on 2024-10-27 21:09:06 - WOPRAI, Joanne Wuensch
  Print publication without navigation


Joanne Wuensch of Citigroup, Maintained "Tandem Diabetes Care, Inc." (TNDM) at Strong Buy with Decreased Target from $155 to $130 on, May 17th, 2022.

Joanne has made no other calls on TNDM in the last 4 months.



There are 4 other peers that have a rating on TNDM. Out of the 4 peers that are also analyzing TNDM, 1 agrees with Joanne's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Danielle Antalffy of "SVB Leerink" Maintained at Hold with Decreased Target to $110 on, Thursday, May 5th, 2022


These are the ratings of the 3 analyists that currently disagree with Joanne


  • Jayson Bedford of "Raymond James" Maintained at Buy with Decreased Target to $125 on, Thursday, May 5th, 2022
  • Matt O'Brien of "Piper Sandler" Maintained at Buy with Decreased Target to $120 on, Thursday, May 5th, 2022
  • Lawrence Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $166 on, Wednesday, February 23rd, 2022
Contributing Sources